Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386773435> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4386773435 endingPage "0544" @default.
- W4386773435 startingPage "jrheum.2023" @default.
- W4386773435 abstract "Children with juvenile dermatomyositis (JDM) and antibodies to antimelanoma differentiation-associated gene 5 (anti-MDA5) are at increased risk of severe disease complications, including interstitial lung disease (ILD). Data regarding treatment of disease complications in this patient population are limited. In this study, we examined the disease course of children with JDM and anti-MDA5 antibodies before and after treatment with rituximab (RTX).Patients aged 2-21 years and seen at the Children's Hospital at Montefiore between July 2012 and August 2021, with a diagnosis of JDM, positive anti-MDA5 antibodies, and evidence of ILD, and who were treated with RTX were eligible for inclusion. Retrospective clinical and laboratory data were reviewed.Five of 8 patients with positive anti-MDA5 antibodies had evidence of ILD (62.5%). Four patients had data available for review. All patients received at least 5 courses of RTX infusions, with discontinuation of steroids by an average of 12 months after starting RTX and a decrease to fewer than 2 concurrent medications by the fifth course of RTX. Indicators of ILD on high-resolution computed tomography and pulmonary function tests either improved or fully resolved over the course of RTX treatment for all patients. Patients also demonstrated resolution of active cutaneous manifestations and musculoskeletal disease activity.To our knowledge, this is the first study to examine the use of RTX in children with JDM and anti-MDA5 antibodies, with notable improvements in ILD, cutaneous, and musculoskeletal manifestations. Further studies are needed to better understand the efficacy of RTX for JDM disease-related complications." @default.
- W4386773435 created "2023-09-16" @default.
- W4386773435 creator A5028152231 @default.
- W4386773435 creator A5054357119 @default.
- W4386773435 creator A5067134065 @default.
- W4386773435 creator A5068037550 @default.
- W4386773435 creator A5079229308 @default.
- W4386773435 creator A5083460869 @default.
- W4386773435 date "2023-09-15" @default.
- W4386773435 modified "2023-10-17" @default.
- W4386773435 title "Clinical improvement in early onset interstitial lung disease using rituximab in children with anti-MDA5 positive juvenile dermatomyositis" @default.
- W4386773435 doi "https://doi.org/10.3899/jrheum.2023-0544" @default.
- W4386773435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37714547" @default.
- W4386773435 hasPublicationYear "2023" @default.
- W4386773435 type Work @default.
- W4386773435 citedByCount "0" @default.
- W4386773435 crossrefType "journal-article" @default.
- W4386773435 hasAuthorship W4386773435A5028152231 @default.
- W4386773435 hasAuthorship W4386773435A5054357119 @default.
- W4386773435 hasAuthorship W4386773435A5067134065 @default.
- W4386773435 hasAuthorship W4386773435A5068037550 @default.
- W4386773435 hasAuthorship W4386773435A5079229308 @default.
- W4386773435 hasAuthorship W4386773435A5083460869 @default.
- W4386773435 hasConcept C126322002 @default.
- W4386773435 hasConcept C159654299 @default.
- W4386773435 hasConcept C16005928 @default.
- W4386773435 hasConcept C187212893 @default.
- W4386773435 hasConcept C203014093 @default.
- W4386773435 hasConcept C2777543607 @default.
- W4386773435 hasConcept C2777714996 @default.
- W4386773435 hasConcept C2778552304 @default.
- W4386773435 hasConcept C2778715236 @default.
- W4386773435 hasConcept C2778751314 @default.
- W4386773435 hasConcept C2779017958 @default.
- W4386773435 hasConcept C2780653079 @default.
- W4386773435 hasConcept C2908647359 @default.
- W4386773435 hasConcept C71924100 @default.
- W4386773435 hasConcept C99454951 @default.
- W4386773435 hasConceptScore W4386773435C126322002 @default.
- W4386773435 hasConceptScore W4386773435C159654299 @default.
- W4386773435 hasConceptScore W4386773435C16005928 @default.
- W4386773435 hasConceptScore W4386773435C187212893 @default.
- W4386773435 hasConceptScore W4386773435C203014093 @default.
- W4386773435 hasConceptScore W4386773435C2777543607 @default.
- W4386773435 hasConceptScore W4386773435C2777714996 @default.
- W4386773435 hasConceptScore W4386773435C2778552304 @default.
- W4386773435 hasConceptScore W4386773435C2778715236 @default.
- W4386773435 hasConceptScore W4386773435C2778751314 @default.
- W4386773435 hasConceptScore W4386773435C2779017958 @default.
- W4386773435 hasConceptScore W4386773435C2780653079 @default.
- W4386773435 hasConceptScore W4386773435C2908647359 @default.
- W4386773435 hasConceptScore W4386773435C71924100 @default.
- W4386773435 hasConceptScore W4386773435C99454951 @default.
- W4386773435 hasLocation W43867734351 @default.
- W4386773435 hasLocation W43867734352 @default.
- W4386773435 hasOpenAccess W4386773435 @default.
- W4386773435 hasPrimaryLocation W43867734351 @default.
- W4386773435 hasRelatedWork W1925884891 @default.
- W4386773435 hasRelatedWork W1973965134 @default.
- W4386773435 hasRelatedWork W2072656517 @default.
- W4386773435 hasRelatedWork W2168509319 @default.
- W4386773435 hasRelatedWork W2387833288 @default.
- W4386773435 hasRelatedWork W2908045723 @default.
- W4386773435 hasRelatedWork W4200525646 @default.
- W4386773435 hasRelatedWork W4247475172 @default.
- W4386773435 hasRelatedWork W4299866916 @default.
- W4386773435 hasRelatedWork W4376559827 @default.
- W4386773435 isParatext "false" @default.
- W4386773435 isRetracted "false" @default.
- W4386773435 workType "article" @default.